In non-small-cell lung carcinoma (NSCLC), lncRNA HOXA-AS3 interacted with HOXA3 and regulated EMT (epithelial-mesenchymal transition) and led to cisplatin resistance55. The gene discussed is HOXA3; the disease is non-small cell lung carcinoma.